Literature DB >> 27979675

Temporal change of myocardial tissue character is associated with left ventricular reverse remodeling in patients with dilated cardiomyopathy: A cardiovascular magnetic resonance study.

Takeru Nabeta1, Takayuki Inomata2, Teppei Fujita1, Yuichiro Iida1, Yuki Ikeda1, Takanori Sato1, Shunsuke Ishii1, Emi Maekawa1, Tomohiro Mizutani1, Takashi Naruke1, Toshimi Koitabashi1, Yusuke Inoue3, Junya Ako1.   

Abstract

BACKGROUND: Prognostic significance of temporal change in myocardial tissue characterization by cardiovascular magnetic resonance (CMR) has not been elucidated in patients with non-ischemic dilated cardiomyopathy (DCM). METHODS AND
RESULTS: Sixty-eight patients with newly-diagnosed DCM who underwent CMR including late gadolinium enhancement (LGE) both at baseline and during follow-up period were enrolled. LGE score was defined by a signal intensity of ≥5 standard deviations above the remote reference myocardium mean. Left ventricular reverse remodeling (LVRR) defined as a LV ejection fraction increase of ≥10% and a decrease in indexed LV end-diastolic diameter of ≥10% compared to those at baseline was detected in 38% of the patients. There was no significant difference in LGE score between baseline and follow-up (5.8% vs. 7.3%; p=0.38). The change in LGE area (delta-LGE) was significantly lower in patients with LVRR than those without (-0.5%±3.4% vs. 3.0±7.4%; p=0.02). On the other hand, T2 ratio during the follow-up significantly reduced (1.95±0.48 vs. 1.67±0.56; p<0.01); however, there was no significant difference in the change in T2 ratio between patients with LVRR and those without (-0.29±0.73 vs. -0.27±0.66; p=0.88). Multivariate logistic analysis indicated that baseline LGE score [odds ratio; 0.78; 95% confidence interval (CI) 0.66 to 0.90; p<0.01] together with delta-LGE (odds ratio; 0.77; 95% CI 0.61 to 0.92; p=0.01) were independently associated with subsequent LVRR (p<0.01).
CONCLUSIONS: The temporal change of LGE-CMR score during the clinical course was significantly correlated with following LVRR.
Copyright © 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dilated cardiomyopathy; Left ventricular reverse remodeling; Magnetic resonance imaging; Myocardial tissue characterization

Mesh:

Substances:

Year:  2016        PMID: 27979675     DOI: 10.1016/j.jjcc.2016.10.017

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  4 in total

1.  Narrowing of the QRS complex, elimination of late gadolinium enhancement and remarkable reverse remodeling achieved by optimal medical treatment in non-ischemic dilated cardiomyopathy.

Authors:  Shusuke Fukuoka; Kaoru Dohi; Yasutaka Ichikawa; Takashi Tanigawa; Hajime Sakuma; Masaaki Ito
Journal:  J Cardiol Cases       Date:  2017-10-26

2.  Reverse Remodeling in Human Heart Failure after Cardiac Resynchronization Therapy Is Associated With Reduced RHO-Kinase Activation.

Authors:  Maria Paz Ocaranza; Jorge E Jalil; Rodrigo Altamirano; Ana de León; Jackeline Moya; Alejandra Lonis; Luigi Gabrielli; Paul Mac Nab; Samuel Córdova; Alejandro Paredes; Ismael Vergara; Alex Bittner; Karime Sabat; Karla Pastorini
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

3.  A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy.

Authors:  Yuki Kimura; Takahiro Okumura; Ryota Morimoto; Shingo Kazama; Naoki Shibata; Hideo Oishi; Takashi Araki; Takashi Mizutani; Tasuku Kuwayama; Hiroaki Hiraiwa; Toru Kondo; Toyoaki Murohara
Journal:  ESC Heart Fail       Date:  2021-01-20

4.  Late gadolinium enhancement for re-worsening left ventricular ejection fraction in patients with dilated cardiomyopathy.

Authors:  Takeru Nabeta; Shunsuke Ishii; Yuki Ikeda; Kenji Maemura; Takumi Oki; Mayu Yazaki; Teppei Fujita; Takashi Naruke; Takayuki Inomata; Junya Ako
Journal:  ESC Heart Fail       Date:  2020-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.